Adam Boxer
Clinical trials sponsored by Adam Boxer, explained in plain language.
-
Could a vaccine tame this rare brain disease?
Disease control ENROLLING_BY_INVITATIONThis study tests a vaccine called AADvac1 in 146 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and thinking. The vaccine aims to target a protein linked to the disease and slow its progression. Participants will receive injections o…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for PSP: experimental drug LM11A-31 enters key trial
Disease control ENROLLING_BY_INVITATIONThis Phase 2 trial tests whether the drug LM11A-31 can slow the progression of Progressive Supranuclear Palsy (PSP), a rare brain disorder that affects movement and balance. About 147 people with early-stage PSP will receive either the drug or a placebo twice daily for several mo…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC